Literature DB >> 35298272

Early detection of cancer.

David Crosby1, Sangeeta Bhatia2,3, Kevin M Brindle4,5, Lisa M Coussens6,7, Caroline Dive8,9, Mark Emberton10, Sadik Esener7,11,12, Rebecca C Fitzgerald13, Sanjiv S Gambhir14, Peter Kuhn15, Timothy R Rebbeck16,17, Shankar Balasubramanian4,18.   

Abstract

Survival improves when cancer is detected early. However, ~50% of cancers are at an advanced stage when diagnosed. Early detection of cancer or precancerous change allows early intervention to try to slow or prevent cancer development and lethality. To achieve early detection of all cancers, numerous challenges must be overcome. It is vital to better understand who is at greatest risk of developing cancer. We also need to elucidate the biology and trajectory of precancer and early cancer to identify consequential disease that requires intervention. Insights must be translated into sensitive and specific early detection technologies and be appropriately evaluated to support practical clinical implementation. Interdisciplinary collaboration is key; advances in technology and biological understanding highlight that it is time to accelerate early detection research and transform cancer survival.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35298272     DOI: 10.1126/science.aay9040

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  14 in total

1.  Cancer Initiates Due to Excessive Self-Renewal and Blocked Differentiation of Tissue-Resident, OCT-4 Positive VSELs.

Authors:  Deepa Bhartiya; Ankita Kaushik; Pushpa Singh; Diksha Sharma
Journal:  Stem Cell Rev Rep       Date:  2022-07-12       Impact factor: 6.692

2.  Deciphering the Immune Complexity in Esophageal Adenocarcinoma and Pre-Cancerous Lesions With Sequential Multiplex Immunohistochemistry and Sparse Subspace Clustering Approach.

Authors:  Srinand Sundaram; Eun Na Kim; Georgina M Jones; Shamilene Sivagnanam; Monika Tripathi; Ahmad Miremadi; Massimiliano Di Pietro; Lisa M Coussens; Rebecca C Fitzgerald; Young Hwan Chang; Lizhe Zhuang
Journal:  Front Immunol       Date:  2022-05-19       Impact factor: 8.786

3.  Combined small and large magnetic nanoparticle extraction and concentration from biofluids for non-toxic detection of biomarkers.

Authors:  Anatoliy S Lapchuk; Ivan V Gorbov; Alexander V Prygun; Iryna V Balagura; Yevhenii M Morozov
Journal:  Sens Diagn       Date:  2022-06-09

4.  Niosome-Assisted Delivery of DNA Fluorescent Probe with Optimized Strand Displacement for Intracellular MicroRNA21 Imaging.

Authors:  Zongwei Zhu; Hongqian Zhang; Xiaoxue Dong; Meng Lin; Chuanxu Yang
Journal:  Biosensors (Basel)       Date:  2022-07-24

5.  Bioinformatics Analysis Revealing the Correlation between NF-κB Signaling Pathway and Immune Infiltration in Gastric Cancer.

Authors:  Qiuxiang Chen; Xiaojing Du; Pengcheng Ruan; Yumei Ye; Jin Zheng; Sunkuan Hu
Journal:  Comput Math Methods Med       Date:  2022-07-28       Impact factor: 2.809

6.  Cancer nanomedicine.

Authors:  Sangeeta N Bhatia; Xiaoyuan Chen; Marina A Dobrovolskaia; Twan Lammers
Journal:  Nat Rev Cancer       Date:  2022-08-08       Impact factor: 69.800

Review 7.  Nanotech Probes: A Revolution in Cancer Diagnosis.

Authors:  Qi Zhang; Kai Hou; Hongbo Chen; Ning Zeng; Yiping Wu
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

Review 8.  Simplifying the complex: accessible microfluidic solutions for contemporary processes within in vitro diagnostics.

Authors:  Nathan K Khosla; Jake M Lesinski; Monika Colombo; Léonard Bezinge; Andrew J deMello; Daniel A Richards
Journal:  Lab Chip       Date:  2022-09-13       Impact factor: 7.517

Review 9.  Extrachromosomal circular DNA (eccDNA): an emerging star in cancer.

Authors:  Ruomeng Li; Ying Wang; Jing Li; Xikun Zhou
Journal:  Biomark Res       Date:  2022-07-26

10.  The Third Joint Meeting on Lung Cancer of the FHU OncoAge (University Côte d'Azur, Nice, France) and the University of Texas MD Anderson Cancer Center (Houston, TX, USA). Understanding New Therapeutic Options and Promising Predictive Biomarkers for Lung Cancer Patients.

Authors:  Paul Hofman; George A Calin; Sandurai A Mani; Christophe Bontoux; Marius Ilié; Ignacio I Wistuba
Journal:  Cancers (Basel)       Date:  2022-09-04       Impact factor: 6.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.